The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease
- PMID: 17651013
- DOI: 10.1089/thy.2007.0003
The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease
Abstract
Graves' disease (GD) is one of the most common thyroid diseases that cause hyperthyroidism. Gestational transient thyrotoxicosis (GTT) is nonautoimmune hyperthyroidism that occurs in women with a normal pregnancy. Postpartum transient thyroiditis (PTT) is a destructive thyroiditis induced by autoimmune mechanism in the postpartum period. Hyperthyroidism due to GD usually tends to improve during the course of gestation and exacerbate after delivery. When the patient with treated GD presents with thyrotoxicosis in the early pregnancy or in the postpartum period, differential diagnosis of exacerbation of GD with GTT or PTT is important because the latter disorders are fundamentally transient. To evaluate the incidence of GTT and PTT in a GD population, we investigated the thyroid functions, thyrotropin receptor antibodies (TRAb), and human chorionic gonadotropin (hCG) during pregnancy and for 1 year after delivery for 39 pregnancies in 34 women with GD. The incidence of GTT was 26% (10/39) of pregnancies. The peak value of hCG in the GTT group ([23.7 +/- 14.5] x 10(4) IU/mL, n = 9) was significantly higher than that in the non-GTT group ([13.3 +/- 4.7] x 10(4) IU/mL, n = 19). The incidence of PTT was 44% (17/39) of deliveries. The free triiodothyronine (FT(3))/free thyroxine (FT(4)) ratio of the exacerbation group of GD (3.1 +/- 1.0, n = 10) at the time of thyrotoxicosis after delivery was significantly higher than that of the PTT group (2.5 +/- 0.4, n = 16). The peak TRAb value of the exacerbation group of GD (72.5 +/- 121.7 IU/L, n = 10) at the time of thyrotoxicosis after delivery was also significantly higher than that of the PTT group (1.4 +/- 0.8 IU/L, n = 16). In conclusion, the high peak value of hCG is valuable for suspecting GTT, and the high FT(3)/FT(4) ratio is valuable for suspecting recurrence in the patients with GD. In both situations, changes of TRAb were also valuable in differentiating the recurrence of GD from GTT or PTT.
Similar articles
-
Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?Endocr J. 2015;62(6):557-60. doi: 10.1507/endocrj.EJ14-0596. Epub 2015 Mar 29. Endocr J. 2015. PMID: 25819223
-
Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.Endocr J. 2005 Aug;52(4):493-7. doi: 10.1507/endocrj.52.493. Endocr J. 2005. PMID: 16127219 Clinical Trial.
-
Gestational and Postpartum Complications in Patients with First Trimester Thyrotoxicosis: A Prospective Multicenter Cohort Study from Northeast China.Thyroid. 2023 Jun;33(6):762-770. doi: 10.1089/thy.2022.0460. Epub 2023 May 8. Thyroid. 2023. PMID: 37051708
-
Pitfalls in the assessment of gestational transient thyrotoxicosis.Gynecol Endocrinol. 2020 Aug;36(8):662-667. doi: 10.1080/09513590.2020.1754391. Epub 2020 Apr 17. Gynecol Endocrinol. 2020. PMID: 32301638 Review.
-
Thyroid dysfunction following pregnancy and implications for breastfeeding.Best Pract Res Clin Endocrinol Metab. 2020 Jul;34(4):101438. doi: 10.1016/j.beem.2020.101438. Epub 2020 Jun 20. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32651061 Review.
Cited by
-
Preconceptional Counseling in Women with Hyperthyroidism.Medicina (Kaunas). 2024 Jan 29;60(2):234. doi: 10.3390/medicina60020234. Medicina (Kaunas). 2024. PMID: 38399522 Free PMC article. Review.
-
Graves' hyperthyroidism in pregnancy: a clinical review.Clin Diabetes Endocrinol. 2018 Mar 1;4:4. doi: 10.1186/s40842-018-0054-7. eCollection 2018. Clin Diabetes Endocrinol. 2018. PMID: 29507751 Free PMC article. Review.
-
Advances in the differential diagnosis of transient hyperthyroidism in pregnancy and Graves' disease.Arch Gynecol Obstet. 2023 Aug;308(2):403-411. doi: 10.1007/s00404-022-06774-z. Epub 2022 Sep 16. Arch Gynecol Obstet. 2023. PMID: 36112207 Review.
-
Transient non-autoimmune hyperthyroidism of early pregnancy.J Thyroid Res. 2011;2011:142413. doi: 10.4061/2011/142413. Epub 2011 Jul 15. J Thyroid Res. 2011. PMID: 21785688 Free PMC article.
-
Thyrotoxicosis of Pregnancy.J Clin Transl Endocrinol. 2014 Dec 1;1(4):140-144. doi: 10.1016/j.jcte.2014.07.008. J Clin Transl Endocrinol. 2014. PMID: 25243108 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical